Search
for
Sort by
Research 661–690 of 883
- The most impactful aspects of living with alopecia areata among patients commencing systemic treatments: Evaluating patients’ perspectives to guide therapy
- Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
- Updated Integrated Efficacy Analysis of Ritlecitinib Up to 3 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials
- Baricitinib Effectiveness and Patient Impressions in Routine Clinical Practice: 12-month Results from a Prospective Observational Real-world Study
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Long‐Term Real‐World Outcomes of Baricitinib in Severe Alopecia Areata: A 104‐Week Retrospective Analysis From a Single Institute
- Baricitinib regrows hair in adolescents with alopecia areata
- Race and Ethnicity Sub-Groups of Alopecia Areata Patients have Differing Clinical Characteristics: TARGET-DERM AA
- Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials
- Depression among Alopecia Areata Patients: Prevalence and associated factors in a Tunisian sample
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- 50524 Facebook groups provide support and product recommendations for patients using scalp cooling to prevent chemotherapy-induced alopecia: A survey study
- Efficacy of modern methods for assessing the severity of alopecia areata
- 131 Patient experiences with alopecia areata: Sentiment analysis of survey responses
- Ciliary Madarosis Secondary to Intra-Arterial Chemotherapy for Retinoblastoma Treatment
- Ayurvedic Management of Pakshmashata (Madarosis): A Case Report
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
- Efficacité à long terme du baricitinib dans le traitement de la pelade : résultats à la semaine 104 des études BRAVE-AA1 et BRAVE-AA2
- Clouston Syndrome: Report of a Jordanian Family with GJB6 Gene Mutation
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Impact and Management of Loss of Eyebrows and Eyelashes
- Madarosis and facial keratinaceous spines
- Micropigmentation
- Unilateral Ciliary Madarosis in a Child After Coronavirus Disease 2019 (COVID-19) Infection
- Signposts to the Promised Land in Alopecia Areata
- 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2
- A qualitative phase I study protocol on developing patient-reported outcome measure for hair, scalp, eyebrows, eyelashes, and beard-related skin disorders
- An eruption of numerous spiny papules in a pediatric transplant patient
- Frontalna fibrozirajuća alopecija
- Aesthetic Management of Upper and Midface Trauma